High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2017.00016
Abstract: Background Signs of an inflammatory process have been described in major depression. Methods In a double-blind, randomized study of celecoxib or placebo add-on to reboxetine in 40 depressed patients, celecoxib treatment has beneficial effects. In… read more here.
Keywords: treatment celecoxib; treatment; remission; major depression ... See more keywords